Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Darmood Wei

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Molecular Cancer Research : MCR|February 1, 2013
SNF5 reexpression in malignant rhabdoid tumors regulates transcription of target genes by recruitment of SWI/SNF complexes and RNAPII to the transcription start site of their promotersYasumichi Kuwahara, Darmood Wei, Joel Durand, et al.
Oncotarget|June 15, 2016
LOX is a novel mitotic spindle-associated protein essential for mitosisMyriem Boufraqech, Darmood Wei, Urbain Weyemi, et al.
Cancer Discovery|May 16, 2019
The Metabolic Basis of Kidney CancerW Marston Linehan, Laura S Schmidt, Daniel R Crooks, et al.
BMC Cancer|September 15, 2019
Preclinical efficacy of dual mTORC1/2 inhibitor AZD8055 in renal cell carcinoma harboring a TFE3 gene fusionEric C Kauffman, Martin Lang, Soroush Rais-Bahrami, et al.
Molecular Cancer Research : MCR|July 11, 2014
SNF5/INI1 deficiency redefines chromatin remodeling complex composition during tumor developmentDarmood Wei, Dennis Goldfarb, Shujie Song, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 16, 2020
A Combinatorial Strategy for Targeting <i>BRAF</i> <sup>V600E</sup>-Mutant Cancers with BRAF<sup>V600E</sup> Inhibitor (PLX4720) and Tyrosine Kinase Inhibitor (Ponatinib)Chandrayee Ghosh, Suresh Kumar, Yevgeniya Kushchayeva, et al.
Molecular Cancer Research : MCR|August 29, 2020
Loss of SWI/SNF Chromatin Remodeling Alters NRF2 Signaling in Non-Small Cell Lung CarcinomaShujie Song, Vinh Nguyen, Travis Schrank, et al.
International Journal of Radiation Oncology, Biology, Physics|November 22, 2017
Mithramycin A Enhances Tumor Sensitivity to Mitotic Catastrophe Resulting From DNA DamageBradley T Scroggins, Jeffrey Burkeen, Ayla O White, et al.
Scientific Reports|December 6, 2019
Proteasome inhibition disrupts the metabolism of fumarate hydratase- deficient tumors by downregulating p62 and c-MycCarole Sourbier, Christopher J Ricketts, Pei-Jyun Liao, et al.
Genes, Chromosomes & Cancer|April 8, 2020
Novel renal medullary carcinoma cell lines, UOK353 and UOK360, provide preclinical tools to identify new therapeutic treatmentsDarmood Wei, Youfeng Yang, Christopher J Ricketts, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Molecular Cancer Research : MCR|February 1, 2013
SNF5 reexpression in malignant rhabdoid tumors regulates transcription of target genes by recruitment of SWI/SNF complexes and RNAPII to the transcription start site of their promotersYasumichi Kuwahara, Darmood Wei, Joel Durand, et al.
Oncotarget|June 15, 2016
LOX is a novel mitotic spindle-associated protein essential for mitosisMyriem Boufraqech, Darmood Wei, Urbain Weyemi, et al.
Cancer Discovery|May 16, 2019
The Metabolic Basis of Kidney CancerW Marston Linehan, Laura S Schmidt, Daniel R Crooks, et al.
BMC Cancer|September 15, 2019
Preclinical efficacy of dual mTORC1/2 inhibitor AZD8055 in renal cell carcinoma harboring a TFE3 gene fusionEric C Kauffman, Martin Lang, Soroush Rais-Bahrami, et al.
Molecular Cancer Research : MCR|July 11, 2014
SNF5/INI1 deficiency redefines chromatin remodeling complex composition during tumor developmentDarmood Wei, Dennis Goldfarb, Shujie Song, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 16, 2020
A Combinatorial Strategy for Targeting <i>BRAF</i> <sup>V600E</sup>-Mutant Cancers with BRAF<sup>V600E</sup> Inhibitor (PLX4720) and Tyrosine Kinase Inhibitor (Ponatinib)Chandrayee Ghosh, Suresh Kumar, Yevgeniya Kushchayeva, et al.
Molecular Cancer Research : MCR|August 29, 2020
Loss of SWI/SNF Chromatin Remodeling Alters NRF2 Signaling in Non-Small Cell Lung CarcinomaShujie Song, Vinh Nguyen, Travis Schrank, et al.
International Journal of Radiation Oncology, Biology, Physics|November 22, 2017
Mithramycin A Enhances Tumor Sensitivity to Mitotic Catastrophe Resulting From DNA DamageBradley T Scroggins, Jeffrey Burkeen, Ayla O White, et al.
Scientific Reports|December 6, 2019
Proteasome inhibition disrupts the metabolism of fumarate hydratase- deficient tumors by downregulating p62 and c-MycCarole Sourbier, Christopher J Ricketts, Pei-Jyun Liao, et al.
Genes, Chromosomes & Cancer|April 8, 2020
Novel renal medullary carcinoma cell lines, UOK353 and UOK360, provide preclinical tools to identify new therapeutic treatmentsDarmood Wei, Youfeng Yang, Christopher J Ricketts, et al.
Pageof 2